Another point to note is that it was only Q2 2024 that Resmed had 529,000 patients in their cohort with prescriptions for both GLP-1 medications and positive airway pressure therapy. They're now up to 660,000 patients in their cohort. That's an additional 130,000 patients! I wouldn't brush over this lightly folks.
A few months ago this article below was published. Apologies if this has already been posted, but well worth reading again.
https://www.morningstar.com.au/insights/stocks/248775/resmeds-impressive-earnings
And just as I highlighted, an untapped market awaits imv the wearable technology market.
Tony
- Forums
- ASX - By Stock
- RMD
- GLP-1 and OSA
GLP-1 and OSA, page-89
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$36.88 |
Change
-0.720(1.91%) |
Mkt cap ! $23.36B |
Open | High | Low | Value | Volume |
$37.36 | $37.42 | $36.84 | $54.23M | 1.466M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11087 | $36.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$36.90 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 202 | 36.800 |
1 | 543 | 36.750 |
1 | 1009 | 36.700 |
1 | 15 | 36.640 |
2 | 850 | 36.600 |
Price($) | Vol. | No. |
---|---|---|
36.900 | 100 | 1 |
37.080 | 250 | 1 |
37.180 | 240 | 1 |
37.300 | 1090 | 1 |
37.400 | 500 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online